Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Kong, US

Consuelo Kong, Cincinnati, OH US

Patent application numberDescriptionPublished
20120021113Rice Flour Compositions - A rice flour composition comprising rice flour having a Water Absorption Index of from about 3.5 to about 9 and a Peak Viscosity of from about 130 RVU to about 900 RVU. Dry blends, doughs, processes of making, and fabricated chips made from the rice flour composition.01-26-2012

Daochun Kong, Rockville, MD US

Patent application numberDescriptionPublished
20110237777FUSION PROTEIN CONTAINING A SINGLE-STRANDED DNA BINDING PROTEIN AND METHODS FOR EXPRESSION AND PURIFICATION OF THE SAME - The present invention provides an expression vector comprising a promoter and a polynucleotide sequence encoding a fusion protein. The present invention further provides a method for purification of an interest protein. The present invention also provides a fusion protein comprising a single-stranded DNA binding protein and an interest protein or polypeptide fused directly or indirectly with the COOH-terminus or NH09-29-2011

Dehe Kong, Walkersville, MD US

Patent application numberDescriptionPublished
20090246269IDENTIFICATION AND USE OF GPRC VARIANTS IN THE TREATMENT AND DIAGNOSIS OF PARKINSON'S DISEASE - The invention relates genes that are deregulated in Parkinson's disease tissues and the corresponding proteins are identified. These genes and the corresponding proteins are suitable targets for the treatment of Parkinson's disease. Also, the invention relates to compounds and their uses, particularly in the pharmaceutical industry. The invention more specifically relates to new uses of compounds that activate the B2 bradykinin receptor, for treating neurodegeneration involving oxidative stress and, more particularly, Parkinson's disease. The invention also relates to corresponding methods of treatment, and can be used in human subjects for preventive or curative treatment, either alone or in combination with other active agents or treatments.10-01-2009

Deying Kong, Vancouver, WA US

Patent application numberDescriptionPublished
20110282313Laminates with Bonded Webs - Laminates with a layer of bonded nonwoven material attached to a layer of film.11-17-2011

James Po Kong, Katy, TX US

Patent application numberDescriptionPublished
20100214069METHOD AND SYSTEM FOR STATE ENCODING - A system comprising at least one piece of equipment; a plurality of sensors adapted to measure one or more operating parameters of the equipment; and a signature generator adapted to encode a plurality of data streams from the sensors into an operating signature for the equipment.08-26-2010
20100219950REMOTE MONITORING SYSTEMS AND METHODS - A method comprising selecting a piece of equipment to be monitored; selecting a plurality of operating parameters to monitor; calculating a deviation for each of the operating parameters; and calculating a composite index for the piece of equipment based on the deviations.09-02-2010
20120016607REMOTE MONITORING SYSTEMS AND METHODS - A system for monitoring an industrial process, comprising one or more sensors connected to one or more operating components of the industrial process; a remote monitoring station, comprising a computer and a database; and a connection between the one or more sensors and the remote monitoring station, wherein the remote monitoring station is at least about 100-2500 miles away from the industrial process, for example 500-1000 miles.01-19-2012

Jian Kong, Canton, MI US

Patent application numberDescriptionPublished
20090107117Diesel Engine Aftertreatment Control Operation with Waste Heat Recovery - A diesel engine exhaust gas aftertreatment system is described. The system may comprise a heat transfer device comprising a first side and a second side; a heater downstream of the first side of the heat transfer device, a filter downstream of the heater; and, an exhaust path downstream of the filter leading to the second side of the heat transfer device, wherein the exhaust path is isolated from an external surface of the filter to inhibit heat transfer from the heated exhaust gas exiting the filter to the external surface of the filter.04-30-2009

K. C. Kong, Ann Arbor, MI US

Patent application numberDescriptionPublished
20090102068SYSTEM AND METHOD TO MANUFACTURE AN IMPLANTABLE ELECTRODE - The method of the preferred embodiments includes the steps of providing a base having a frame portion and a center portion; building a preliminary structure coupled to the base; removing a portion of the preliminary structure to define a series of devices and a plurality of bridges; removing the center portion of the base such that the frame portion defines an open region, wherein the plurality of bridges suspend the series of devices in the open region defined by the frame; and encapsulating the series of devices. The method is preferably designed for the manufacture of semiconductor devices, and more specifically for the manufacture of encapsulated implantable electrodes. The method, however, may be alternatively used in any suitable environment and for any suitable reason.04-23-2009
20090240314IMPLANTABLE ELECTRODE LEAD SYSTEM WITH A THREE DIMENSIONAL ARRANGEMENT AND METHOD OF MAKING THE SAME - One embodiment of the invention includes an implantable electrode lead system that includes a series of shims stacked upon each other, a series of first components, and a series of second components connected to the series of first components through a series of connectors. One of the first components extends from one of the shims, and another of the first components extends from another one of the shims. The shims position the first components in a three dimensional arrangement.09-24-2009
20110112591Waveguide neural interface device - A waveguide neural interface device including: a neural device implantable in tissue and including an array of electrode sites that electrically communicate with their surroundings, in which the array of electrode sites includes at least one recording electrode site; and a waveguide, coupled to the neural device, that carries light along a longitudinal axis and includes a light directing element that redirects the carried light from the waveguide to illuminate selectively targeted tissue, in which at least a portion of the redirected light is directed laterally away from the longitudinal axis and the recording electrode site is configured to sample illuminated tissue. A method for assembling a waveguide neural interface device is also described.05-12-2011

Linghua Kong, Marietta, GA US

Patent application numberDescriptionPublished
20090076732SYSTEMS AND METHODS FOR THE ANALYSIS OF MECHANICAL PROPERTIES OF MATERIALS - The various embodiments of the present invention relate generally to the analysis of the mechanical properties of materials. More particularly, the various embodiments of the present invention relates to systems and methods of deriving the static and dynamic mechanical properties of deformative materials, for example, but not limited to, biological surfaces. The systems and methods of the present invention can be used to derive and evaluate the mechanical properties of many biological surfaces and subsurfaces, including but not limited to the skin.03-19-2009
20100140461SYSTEMS AND METHODS FOR REAL TIME MULTISPECTRAL IMAGING - Multispectral filter arrays and methods of making and using the arrays are described herein. Multispectral imaging systems and methods of making and using the systems are also described. A multispectral filter array includes a mosaic of light sensitive elements that includes a first element sensitive to a first narrow spectral region, a second element sensitive to a second narrow spectral region, and a third element sensitive to a third narrow spectral region. A multispectral imaging system includes an illumination system having at least three lighting elements, each of which are configured to transmit light at a different wavelength, and the multispectral filter array.06-10-2010

Ling Quan Kong, Hockessin, DE US

Patent application numberDescriptionPublished
20110224190PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS - The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.09-15-2011

Ling Y. Kong, Houston, TX US

Patent application numberDescriptionPublished
20100144802Small Molecule Inhibitors for Immune Modulation - Methods of treating immunosuppression by administering a therapeutic amount of a tryphostin compound of the formula:06-10-2010

Lingzhao Kong, Auburn, AL US

Patent application numberDescriptionPublished
20110179703BIOMASS TO BIOCHAR CONVERSION IN SUBCRITICAL WATER - The present invention relates to a method for conversion of biomass to biochar in subcritical water at 230-350° C. and 500-3000 psi. Under subcritical water conditions, biomass readily converts into biochar, biocrude, and some gases. In this invention, yield of biochar is significantly improved by recycling of biocrude. The process can produce hydrophobic biochar that has at least 70 wt % (dry basis) carbon as opposed to ˜25 wt % carbon in hydrophilic biomass, and has a heating value of about 29 MJ/kg (HHV-dry basis) which is comparable to good quality coals. More than 90% energy of biomass is retained in the biochar. The invention provides an effective means to convert biomass into a high energy density fuel for use in a variety of applications.07-28-2011

Peter C. Kong, Idaho Falls, ID US

Patent application numberDescriptionPublished
20080305026METHOD FOR PRODUCING A BOROHYDRIDE - A method for producing a borohydride is described and which includes the steps of providing a source of borate; providing a material which chemically reduces the source of the borate to produce a borohydride; and reacting the source of borate and the material by supplying heat at a temperature which substantially effects the production of the borohydride.12-11-2008
20100270142COMBUSTION FLAME PLASMA HYBRID REACTOR SYSTEMS, CHEMICAL REACTANT SOURCES AND RELATED METHODS - Combustion flame-plasma hybrid reactor systems, chemical reactant sources, and related methods are disclosed. In one embodiment, a combustion flame-plasma hybrid reactor system comprising a reaction chamber, a combustion torch positioned to direct a flame into the reaction chamber, and one or more reactant feed assemblies configured to electrically energize at least one electrically conductive solid reactant structure to form a plasma and feed each electrically conductive solid reactant structure into the plasma to form at least one product is disclosed. In an additional embodiment, a chemical reactant source for a combustion flame-plasma hybrid reactor comprising an elongated electrically conductive reactant structure consisting essentially of at least one chemical reactant is disclosed. In further embodiments, methods of forming a chemical reactant source and methods of chemically converting at least one reactant into at least one product are disclosed.10-28-2010
20110236272CHEMICAL REACTOR FOR CONVERTING A FIRST MATERIAL INTO A SECOND MATERIAL - A chemical reactor and method for converting a first material into a second material is disclosed and wherein the chemical reactor is provided with a feed stream of a first material which is to be converted into a second material; and wherein the first material is combusted in the chemical reactor to produce a combustion flame, and a resulting gas; and an electrical arc is provided which is passed through or superimposed upon the combustion flame and the resulting gas to facilitate the production of the second material.09-29-2011

Patent applications by Peter C. Kong, Idaho Falls, ID US

Peter Chuen Sun Kong, Idaho Falls, ID US

Patent application numberDescriptionPublished
20090188898Electrode Assemblies, Plasma Apparatuses and Systems Including Electrode Assemblies, and Methods for Generating Plasma - Electrode assemblies for plasma reactors include a structure or device for constraining an arc endpoint to a selected area or region on an electrode. In some embodiments, the structure or device may comprise one or more insulating members covering a portion of an electrode. In additional embodiments, the structure or device may provide a magnetic field configured to control a location of an arc endpoint on the electrode. Plasma generating modules, apparatus, and systems include such electrode assemblies. Methods for generating a plasma include covering at least a portion of a surface of an electrode with an electrically insulating member to constrain a location of an arc endpoint on the electrode. Additional methods for generating a plasma include generating a magnetic field to constrain a location of an arc endpoint on an electrode.07-30-2009

Qingjun Kong, Elmhurst, NY US

Patent application numberDescriptionPublished
20100217356Method to reduce heating at implantable medical devices including neuroprosthetic devices - A method to control tissue/device heating at implantable medical devices including neuroprosthetic devices. In a first embodiment, thermal conductivity of components of the implantable medical devices including the neuroprosthetic devices is increased. In a second embodiment, the implantable medical devices including the neuroprosthetic devices are cooled by using heat-sinks. In a third embodiment, portions of the implantable medical devices including the neuroprosthetic devices are replaced with specific thermal properties. In a fourth embodiment, the implantable medical devices including the neuroprosthetic devices are coated with a drug/material that will induce surrounding tissue to become more resistant to temperature increases. In a fifth embodiment, the temperature increase near the implantable devices including the neuroprosthetic devices is determined using a modified bio-heat transfer model. In a sixth embodiment, the shape of the outer or the inner surface of the device is modified.08-26-2010

Qingke Kong, Tempe, AZ US

Patent application numberDescriptionPublished
20110287052RECOMBINANT BACTERIUM CAPABLE OF ELICITING AN IMMUNE RESPONSE AGAINST STREPTOCOCCUS PNEUMONIAE - The invention encompasses a recombinant bacterium capable of eliciting an immune response against 11-24-2011

Randy Yuan Kong, Kirkland, WA US

Patent application numberDescriptionPublished
20080309617Graphical communication user interface - New devices, systems and methods are hereby provided that enable a user to open a communication channel by selecting an image on a monitor. A device that includes a monitor and a graphical position user input mechanism is configured to display one or more images on the monitor, to receive a graphical position user input selecting one of the images, and to open a communication channel directed to a contact information element associated with the selected image. For example, this may include placing a phone call to a selected recipient, or opening an email, instant messaging, or text message composition panel addressed to a selected recipient, by touching, clicking on, or otherwise selecting an image of the recipient, or an image that is associated with the recipient.12-18-2008

Savan Kong, Seattle, WA US

Patent application numberDescriptionPublished
20100198684INTERACTIVE MAP-BASED SEARCH AND ADVERTISING - A computer system locates objects and content by navigating an aerial or satellite image map of a geographic region. The system determines a search region corresponding to the geographic region by use of geospatial information associated with the geographic region. Once the search region is determined, the system searches a database for objects and content that are associated with the search region and that satisfy certain predetermined criteria and characteristics. Relevant ads are then shown to the user within an interactive mapping experience.08-05-2010

Steven H. Kong, Woodbury, MN US

Patent application numberDescriptionPublished
20110032449PERFORATED BACKLIGHT - A backlight includes a lower light guide having a specularly reflecting bottom surface and an opposing specularly reflecting perforated mirror film having a plurality of light transmission apertures. The specularly reflecting perforated mirror film has a polymeric multilayer structure, where non-perforated areas of the specularly reflecting perforated mirror film have a light reflectance value of 98% or greater and the specularly reflecting bottom surface has a light reflectance value of 98% or greater. A light collimating injector directs input light into the lower light guide. The light propagating generally parallel to the specularly reflecting perforated mirror film along a horizontal plane. The light collimating injector provides input rays into a vertical plane, the vertical plane being orthogonal to the horizontal plane, and forming an angle having an absolute value of 30 degrees or less with an intersection of the vertical and horizontal planes. An upper light cavity is disposed on the lower light guide. The upper light cavity has a light emission surface and a light input surface. The light input surface is at least partially defined by the specularly reflecting perforated mirror film. The upper light cavity has a thickness defined by the light emission surface and the light input surface. The thickness is equal to or greater than a distance between adjacent light transmission apertures.02-10-2011
20120064296ANTIGLARE FILMS COMPRISING MICROSTRUCTURED SURFACE - The present invention concerns antiglare films having a microstructured surface.03-15-2012

Patent applications by Steven H. Kong, Woodbury, MN US

Wei Kong, Phoenix, AZ US

Patent application numberDescriptionPublished
20100124558REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY - The invention relates to compositions and methods for making and using recombinant bacteria that are capable of regulated attenuation and/or regulated expression of one or more antigens of interest.05-20-2010

Wendell Kong, Hollis, NH US

Patent application numberDescriptionPublished
20080241757Reproducible, high yield method for fabricating ultra-short T-gates on HFETs - A method for fabricating ultra-short T-gates on heterojunction field effect transistors (HFETs) comprising the steps of (a) providing a coating of three layers of resists, with polymethylmethacrylate (PMMA) with high molecular weight on the bottom, polydimethylglutarimide (PMGI) in the middle, and PMMA with low molecular weight on the top; (b) in a first exposure, exposing and developing the layers with a dose of a developer that is high enough to allow the developer to break the top PMMA but low to avoid contributing significantly to the overall dose received in the bottom PMMA layer; and (c) in a second exposure, using an exposure and developing process to define 0.03-0.05 um openings in the bottom PMMA layer.10-02-2008
20100301395Asymmetrically recessed high-power and high-gain ultra-short gate HEMT device - A high-power and high-gain ultra-short gate HEMT device has exceptional gain and an exceptionally high breakdown voltage provided by an increased width asymmetric recess for the gate electrode, by a composite channel layer including a thin indium arsenide layer embedded in the indium gallium arsenide channel layer and by double doping through the use of an additional silicon doping spike. The improved transistor has an exceptional 14 dB gain at 110 GHz and exhibits an exceptionally high 3.5-4 V breakdown voltage, thus to provide high gain, high-power and ultra-high frequency in an ultra-short gate device.12-02-2010

William Kong, State College, PA US

Patent application numberDescriptionPublished
20100040815Energy Absorbing Stitch Ripping Composite Tubes Containing Collapsible Cells - An energy absorbing system has an inner tube and an outer tube that are stitched together. The inner tube contains a set of fibers oriented in a first direction and the outer tube has a second set of fibers oriented in a direction different from the first direction. Preferably these orientations are equal and opposite to each other. The inner tube may be hollow, but preferably has a cellular core. The outer tube may be spaced apart from the inner tube to create an annular cavity that is filled with a cellular material.02-18-2010

Wing Han Kong, Whitestone, NY US

Patent application numberDescriptionPublished
20110142373Flexibly collapsible bag for being self-stored in itself in two different places thereof - A flexibly collapsible bag for being self-stored in itself in two different places thereof so as to form two different appearances so as to allow for better coordination with other apparel. The bag includes a bag body, a flexible internal pouch, and a relatively firm and bendable external pouch. The flexible internal pouch is attached internally to the bag body. The relatively firm and bendable external pouch is attached externally to the bag body. The bag body is either foldably and compressibly stored in the flexible internal pouch to form the first appearance or is foldably, compressibly, and rollably stored under the relatively firm and bendable external pouch to form the second appearance so as to allow for the better coordination with the other apparel.06-16-2011

Wing-Pui Kong, Germantown, MD US

Patent application numberDescriptionPublished
20080286306HIV vaccines based on Env of multiple clades of HIV - In one embodiment, the invention provides a multiclade HIV plasmid DNA or viral vector vaccine including components from different clades of Env (optionally Env chimeras) and Gag-Pol-(optionally)Nef from a single clade. The vaccine of the invention may further include V1, V2, V3, or V4 deletions or combinations thereof. In another embodiment, the invention provides multiclade HIV envelope immunogens.11-20-2008
20090208531ANTIVIRAL AGENTS AND VACCINES AGAINST INFLUENZA - These vaccines target H5N1, H1, H3 and other subtypes of influenza and are designed to elicit neutralizing antibodies, as well as cellular immunity. The DNA vaccines express hemagglutinin (HA) or nucleoprotein (NP) proteins from influenza which are codon optimized and/or contain modifications to protease cleavage sites of HA which affect the normal function of the protein. Adenoviral constructs expressing the same inserts have been engineered for prime boost strategies. Protein-based vaccines based on protein production from insect or mammalian cells using foldon trimerization stabilization domains with or without cleavage sites to assist in purification of such proteins have been developed. Another embodiment of this invention is the work with HA pseudotyped lentiviral vectors which would be used to screen for neutralizing antibodies in patients and to screen for diagnostic and therapeutic antivirals such as monoclonal antibodies.08-20-2009
20090286860Method of using adenoviral vectors to induce an immune response - The invention provides a method of inducing an immune response against a human immunodeficiency virus (HIV) in a mammal. The method comprises administering to the mammal an adenoviral vector composition comprising one or more adenoviral vectors encoding two or more different HIV antigens, the production of which induces an immune response against HIV in the mammal. The invention also provides an adenoviral vector composition comprising four adenoviral vectors encoding an HIV clade A Env protein, an HIV clade B Env protein, an V clade C Env protein, and a fusion protein comprising an HIV clade B Gag protein and Pol protein, respectively.11-19-2009
20100074916AVIAN INFLUENZA VACCINE - H5 hemagglutinin (HA) polypeptides are provided that are adapted to humans through mutations that change receptor specificity in the H1 serotype, and related polynucleotides, methods, compositions, and vaccines.03-25-2010
20110171260INFLUENZA DNA VACCINATION AND METHODS OF USE THEREOF - The present invention relates to an influenza immunogen that includes one or more DNA constructs encoding at least two divergent influenza HAs, wherein each of such one or more DNA constructs encodes one or more of the at least two divergent influenza HAs. Such an immunogen, when administered to a subject, induces an immune response to a plurality of strains of influenza virus, wherein at least one strain of the plurality of strains does not encode any of the divergent influenza HAs encoded by the immunogen. The divergent influenza HAs can be swine influenza HAs or equine influenza HAs, such as influenza H1 HAs or influenza H3 HAs. The invention also relates to a method to use such an immunogen to induce such an immune response as well as to DNA constructs comprising such divergent influenza HAs. Such an immunogen can provide a heterologous as well as a homologous immune response. Such an immunogen can be used to induce an immune response against evolving influenza virus.07-14-2011
20110274721HIV VACCINES BASED ON ENV OF MULTIPLE CLADES OF HIV - In one embodiment, the invention provides a multiclade HIV plasmid DNA or viral vector vaccine including components from different clades of Env (optionally Env chimeras) and Gag-Pol-(optionally)Nef from a singlr clade. The vaccine of the invention may further include V1, V2, V3, or V4 deletions or combinations thereof. In another embodiment, the invention provides multiclade HIV envelope immunogens.11-10-2011

Patent applications by Wing-Pui Kong, Germantown, MD US

Wing-Pui Kong, Gaithersburg, MD US

Patent application numberDescriptionPublished
20100111998HIV VACCINES BASED ON ENV OF MULTIPLE CLADES OF HIV - In one embodiment, the invention provides a multiclade HIV plasmid DNA or viral vector vaccine including components from different clades of Env (optionally Env chimeras) and Gag-Pol-(optionally)Nef from a single Glade. The vaccine of the invention may further include V1, V2, V3, or V4 deletions or combinations thereof. In another embodiment, the invention provides multiclade HIV envelope immunogens.05-06-2010

Xiang-Peng Kong, New York, NY US

Patent application numberDescriptionPublished
20090098144IMMUNOGEN PRESENTING HIV GP120 V3 LOOP IN A CONFORMATION THAT INDUCES BROADLY NEUTRALIZING ANTIBODIES - Insertion of HIV-1 V3 loop peptides from the viral glycoprotein gp120 into selected, immunogenic scaffold proteins results in a recombinant polypeptide that is a potent V3 immunogen. V3 immunogens include natural and consensus V3 sequences and cyclic and reverse peptides. Preferred scaffold proteins are Cholera Toxin subunit B and homologues thereof including closely related 04-16-2009

Xiaoyuan Kong, Tampa, FL US

Patent application numberDescriptionPublished
20080214437Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases - Methods, compositions and devices are provided by the present invention for reducing activity of a natriuretic peptide receptor and other signals. Therapeutic treatments are provided by use of polynucleotides encoding a natriuretic peptide or by regulating the expression of natriuretic peptide receptor, such as NPRA and NPRC, or combinations of these therapies. Routes used for delivering polynucleotides encoding a natriuretic peptide, or, for example, siRNA that down regulates natriuretic peptide receptor include subcutaneous injection, oral gavage, transdermal and intranasal delivery routes. Compositions can include chitosan, chitosan derivatives, and chitosan derivative and a lipid. Transdermal delivery can use a transdermal cream. Intranasal delivery can use a dropper or an aspirator for delivery of a mist. Oral gavage delivers equivalent to oral delivery. Delivery permits cell and tissue specific targeting of gene therapies resulting in expression of a natriuretic peptide or down regulation of natriuretic peptide receptor. A variety of cancers, asthma and viral diseases can be treated therapeutically using the methods and compositions of the present invention.09-04-2008
20100260725Materials and Methods for Treating Allergic and Inflammatory Conditions - The subject invention provides for the utilization of bone-marrow derived stem cells in the treatment of allergic and inflammatory diseases. In one embodiment, the invention provides for treatment of asthma. Bone-marrow derived stem cells can be used for decreasing inflammation and alter the course of immune response in the lung.10-14-2010

Patent applications by Xiaoyuan Kong, Tampa, FL US

Xinxin Kong, Sugar Land, TX US

Patent application numberDescriptionPublished
20100251135GEOLOGICAL AND GEOPHYSICAL, VISUALIZATION AND INTERPRETATION SOFTWARE BOOKMARKS - A method for creating a bookmark for geological and geophysical, visualization and interpretation software is described herein. A visualization of seismic or borehole data may be displayed on a computer screen. A request to create the bookmark may be received. The bookmark may represent a state of the displayed visualization and include one or more settings of the GGVI software. The settings may be determined. The bookmark may be created.09-30-2010

Xuehan Kong, Farmington Hills, MI US

Patent application numberDescriptionPublished
20100217472SECURING DRIVER REQUESTED TORQUE - An engine control system comprises a driver axle torque request module (DATRM) and a driver axle torque security module (DATSM). The DATRM determines a pedal torque request based on minimum and maximum scaling torques and a torque scalar. The DATRM determines a raw driver torque request. The DATRM selectively shapes raw driver torque request into a final driver torque request. The DATRM converts the final driver torque request into a first axle torque request. The DATSM selectively diagnoses a fault in the first axle torque request based on a minimum engine torque, the minimum scaling torque, a first comparison of the final driver torque request and the redundant final driver torque request, and a second comparison of the first axle torque request and a redundant axle torque request.08-26-2010

Yali Kong, Centreville, VA US

Patent application numberDescriptionPublished
20100004179TARGETING OF EWS-FLI1 AS ANTI-TUMOR THERAPY - Peptides and compounds are provided that function as EWS-FLI1 protein inhibitors. The peptides and compounds have utility in the treatment of Ewing's sarcoma family of tumors. Also provided are methods of preparing the compounds and assays for identifying inhibitors of EWS-FLI1 protein.01-07-2010
20100167994TARGETING OF EWS-FLI1 AS ANTI-TUMOR THERAPY - Peptides and compounds are provided that function as EWS-FLI1 protein inhibitors. The peptides and compounds have utility in the treatment of Ewing's sarcoma family of tumors. Also provided are methods of preparing the compounds and assays for identifying inhibitors of EWS-FLI1 protein.07-01-2010
20100317739HISTONE DEACETYLASE INHIBITORS - Novel histone deacetylase inhibitors, including novel fluorescent histone deacetylase inhibitors, are described. Methods for making and using the same, e.g., to treat cancer, are provided.12-16-2010

Yanping Kong, Merrimack, NH US

Patent application numberDescriptionPublished
20120070373METHOD AND COMPOUND FOR TREATMENT OF CANCER USING PHOSPHOROUS-32 LABELED DNA - This invention provides a combination of a gene and isotope therapy that is applied to a cancerous tissue to selectively kill that associated cancer cells with minimal negative effects on surrounding non-cancerous cells. Functionally, the specific DNA fragments with labeled isotope are able to bind the tumor cells DNA through recombination, and then the isotope kills the tumor cells. A gene is employed as a carrier to deliver the P-32 which can kill cancer cells through radioactive emission. Unlike traditional gene therapy, which employs a gene to express a protein, which can suppress the cancer cell growth or increase the sensitivity for radiation therapy or chemotherapy, the illustrative embodiment actually binds the radioactive substance via a gene. The illustrative embodiment produces the compound/agent containing a gene (DNA fragment) and P-32 through use of conventional P-32 labeling techniques such as those employed in molecular biology experiments (for example experiments used to test gene expression and gene amplification potency). In the illustrative embodiment, however, the same P-32 labeled DNA is employed directly for cancer treatment through a novel medical treatment method. Appropriate doses are provided to patients as part of a medical treatment method.03-22-2012

Yingjie Kong, East Lyme, CT US

Patent application numberDescriptionPublished
20090033039Gasket with asymmetric bead arrangement - An asymmetric bead formed in a gasket is provided. The gasket defines a plane. The bead includes a first half emboss portion positioned at a first angle to the plane of the gasket. A bead top portion is positioned parallel to the plane of the gasket and is connected to the first half emboss portion. A second half emboss portion is positioned at a second angle to the plane of the gasket and is connected to the bead top portion. The first angle is greater than the second angle so that the length of the first half emboss portion is shorter than the second half emboss portion and therefore, has a smaller surface area being acted on by a higher pressure fluid on the first half emboss portion so that the forces acting on the first and second half emboss portions are equalized.02-05-2009

Zhenning Kong, New Haven, CT US

Patent application numberDescriptionPublished
20090265141DISTRIBUTED STORAGE IN WIRELESS SENSOR NETWORKS - The present invention provides a method for implementation in a first sensor node that is a member of a sensor node network including a plurality of sensor nodes. One embodiment of the method includes accessing, at the first sensor node, information indicative of a sensing operation performed by at least one of the plurality of sensor nodes. This embodiment of the method also includes randomly selecting, at the first sensor node, a second sensor node that is adjacent the first sensor node in the sensor node network. The random selection is made independent of a location of the second sensor node. This embodiment of the method further includes transmitting the information indicative of the sensing operation from the first sensor node to the second sensor node.10-22-2009

Zhike Kong, Sammamish, WA US

Patent application numberDescriptionPublished
20100306827Opaque Quarantine and Device Discovery - Embodiments described herein provide communication control features and functionality, but are not so limited. In an embodiment, a computing environment includes an access control component that can use a number of access states to control access to computing data and/or services. In one embodiment, a server computer can control access to data and/or services using a number of access states including, but not limited to: an allowed state, a blocked state, a device discovery state, and/or a quarantined state. Other embodiments are available.12-02-2010

Zinquo Kong, Akron, OH US

Patent application numberDescriptionPublished
20100225199NANOPOROUS MATERIALS FOR USE IN INTELLIGENT SYSTEMS - The present invention relates to volume and/or shape memory systems for which the volume and/or shape can be adjusted by controlling one or more variables such as applied voltage and temperature. In one embodiment, the volume and/or shape memory systems of the present invention are controlled and/or adjusted by way of a temperature mechanism. In another embodiment, the volume and/or shape memory systems of the present invention are controlled and/or adjusted by way of a voltage mechanism. In still another embodiment, the present invention provides a device that contains, in part, a smart volume and/or shape memory material that exhibits high energy densities, and can provide large displacements over broad temperature and/or voltage ranges.09-09-2010